New Evidence of Probucol on Cardiovascular Events.
作者信息
Hirata Ken-Ichi
机构信息
The Cardiovascular Medicine, Kobe University Graduate School of Medicine.
出版信息
J Atheroscler Thromb. 2021 Feb 1;28(2):97-99. doi: 10.5551/jat.ED155. Epub 2020 Nov 21.
Abstract
摘要
相似文献
1
New Evidence of Probucol on Cardiovascular Events.
J Atheroscler Thromb. 2021 Feb 1;28(2):97-99. doi: 10.5551/jat.ED155. Epub 2020 Nov 21.
2
New Horizons for Probucol, an Old, Mysterious Drug.
J Atheroscler Thromb. 2021 Feb 1;28(2):100-102. doi: 10.5551/jat.ED132. Epub 2020 Jun 5.
3
[Mechanisms of anti-atherogenic action of probucol].
Nihon Rinsho. 1999 Dec;57(12):2831-6.
4
Dissociating HDL cholesterol from cardiovascular risk.
Lancet. 2010 Jul 31;376(9738):305-6. doi: 10.1016/S0140-6736(10)61021-5. Epub 2010 Jul 23.
5
Probucol alleviates atherosclerosis and improves high density lipoprotein function.
Lipids Health Dis. 2011 Nov 12;10:210. doi: 10.1186/1476-511X-10-210.
6
Probucol normalizes cholesteryl ester transfer in IDDM.
Diabetes Care. 1995 Oct;18(10):1341-6. doi: 10.2337/diacare.18.10.1341.
7
[Probucol].
Nihon Rinsho. 2007 Jul 28;65 Suppl 7:470-5.
8
High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins.
Eur J Clin Invest. 1997 Apr;27(4):285-92. doi: 10.1046/j.1365-2362.1997.1040657.x.
9
Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence.
Vasc Health Risk Manag. 2013;9:671-80. doi: 10.2147/VHRM.S52713. Epub 2013 Oct 31.
10
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Circulation. 2019 Nov 5;140(19):1578-1589. doi: 10.1161/CIRCULATIONAHA.119.042551. Epub 2019 Sep 2.
引用本文的文献
1
Effect of Probucol and Atorvastatin Treatment on the Self-Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study.
Brain Behav. 2025 May;15(5):e70552. doi: 10.1002/brb3.70552.
2
Accelerating antiviral drug discovery: early hazard detection with a dual zebrafish and cell culture screen of a 403 compound library.
Arch Toxicol. 2025 Mar;99(3):1029-1041. doi: 10.1007/s00204-024-03948-3. Epub 2024 Dec 27.
3
Probucol will become a new model for treating cerebral infarction with a high risk of hemorrhage: A narrative review.
Brain Circ. 2023 Nov 30;9(4):222-227. doi: 10.4103/bc.bc_44_23. eCollection 2023 Oct-Dec.
4
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases.
Transl Neurodegener. 2024 Jan 22;13(1):6. doi: 10.1186/s40035-024-00398-w.
本文引用的文献
1
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).
J Atheroscler Thromb. 2021 Feb 1;28(2):103-123. doi: 10.5551/jat.55327. Epub 2020 Apr 24.
2
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis.
Eur J Prev Cardiol. 2019 Mar;26(5):533-543. doi: 10.1177/2047487318816495. Epub 2018 Dec 6.
3
Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
PLoS One. 2015 Apr 21;10(4):e0124021. doi: 10.1371/journal.pone.0124021. eCollection 2015.
4
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Lancet. 2015 Apr 11;385(9976):1397-405. doi: 10.1016/S0140-6736(14)61368-4. Epub 2015 Jan 9.
5
Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan.
J Atheroscler Thromb. 2008 Dec;15(6):292-303. doi: 10.5551/jat.e610. Epub 2008 Dec 6.
6
Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2422-7. doi: 10.1161/01.ATV.0000185834.98941.3d. Epub 2005 Sep 8.
7
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
Am J Cardiol. 1994 Nov 1;74(9):875-83. doi: 10.1016/0002-9149(94)90579-7.
8
A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
J Lipid Res. 1984 Nov;25(11):1206-13.
9
Probucol inhibits oxidative modification of low density lipoprotein.
J Clin Invest. 1986 Feb;77(2):641-4. doi: 10.1172/JCI112349.
10
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5928-31. doi: 10.1073/pnas.84.16.5928.
Zotero 插件